Abstract
Objective The World Health Organisation recommends exclusive breastfeeding for the first six months of life. This study aimed to examine 1) If intention to breastfeed is associated with higher levels of breastfeeding, and 2) If the pandemic impacted the intention to breastfeed and the breastfeeding rates in Wales.
Methods This was a cohort study utilising routinely collected, linked healthcare data from the Secure Anonymised Information Linkage databank (SAIL). SAIL combines data from the National Community Child Health (NCCH) and Maternal Indicators (MIDS) datasets. All women that gave birth between 2018 and 2021 recorded in the NCCH dataset and MIDS dataset were included.
Results Intention to breastfeed was associated with being 27.5 times more likely to continue to breastfeed for six months compared to those who did not intend to breastfeed (OR 27.5, 95% CI: 24.8-30.5). 57.8% of expectant mothers intended to breastfeed pre-pandemic and 58.7% intended to breastfeed in 2020. Exclusive breastfeeding rates to six months were 16.6% pre-pandemic, 20.5% in 2020 and 19.7% in 2021. Those aged 30-39 were 3.91 times more likely to breastfeed.
Conclusion The biggest predictor of exclusive breastfeeding at six months was intention to breastfeed. During the pandemic those who intended to breastfeed were more likely to breastfeed exclusively for six months compared to before and after the pandemic, suggesting time at home may facilitate breastfeeding. Therefore, targeted interventions during pregnancy planning and early pregnancy to promote and encourage intention to start breastfeeding and promoting home working could improve breastfeeding rates and duration.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the National Centre for Population Health and Wellbeing Research (NCPHWR)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Greater Manchester East Ethics Committee gave ethical approval for this work. IRAS Number: 299760 Protocol Number: RIO 030-20 REC Reference 21/NW/0156
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
